Clinical implications of somatic allele expansion in female FMR1 premutation carriers
Authors:
Open Access
- 29 April 2023
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Abstract
Carriers of a premutation allele (PM) in the FMR1 gene are at risk of developing a number of Fragile X premutation asssociated disorders (FXPAC), including Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), Fragile X-associated Primary Ovarian Insufficiency (FXPOI), and Fragile X-associated neuropsychiatric disorders (FXAND). We have recently reported somatic CGG allele expansion in female PM; however, its clinical significance remains unclear. The aim of this study was to examine the potential clinical association between somatic FMR1 allele instability and PM associated disorders. Participants comprised of 424 female PM carriers age 0.3– 90 years. FMR1 molecular measures and clinical information on the presence of medical conditions, were determined for all subjects for primary analysis. Two sub-groups of participants (age ≥ 25, N = 377 and age ≥ 50, N = 134) were used in the analysis related to presence of FXPOI and FXTAS, respectively. Among all participants (N = 424), the degree of instability (expansion) was significantly higher (median 2.5 vs 2.0, P = 0.026) in participants with a diagnosis of attention deficit hyperactivity disorder (ADHD) compared to those without. FMR1 mRNA expression was significantly higher in subjects with any psychiatric disorder diagnosis (P = 0.0017); specifically, in those with ADHD (P = 0.009), and with depression (P = 0.025). Somatic FMR1 expansion was associated with the presence of ADHD in female PM and FMR1 mRNA levels were associated with the presence of mental health disorders. The findings of our research are innovative as they suggest a potential role of the CGG expansion in the clinical phenotype of PM and may potentially guide clinical prognosis and management.Keywords
Funding Information
- National Institutes of Health (HD036071)
This publication has 45 references indexed in Scilit:
- The FMR1 Premutation and Attention-Deficit Hyperactivity Disorder (ADHD): Evidence for a Complex InheritanceBehavior Genetics, 2011
- The Role of AGG Interruptions in the Transcription of FMR1 Premutation AllelesPLOS ONE, 2011
- Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndromeHuman Molecular Genetics, 2011
- A Novel FMR1 PCR Method for the Routine Detection of Low Abundance Expanded Alleles and Full Mutations in Fragile X SyndromeClinical Chemistry, 2010
- Evidence for RNA-Mediated Toxicity in the Fragile X-Associated Tremor/Ataxia SyndromeFuture Neurology, 2009
- Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degenerationHuman Molecular Genetics, 2009
- Co‐occurring conditions associated with FMR1 gene variations: Findings from a national parent surveyAmerican Journal of Medical Genetics Part A, 2008
- A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk PopulationsThe Journal of Molecular Diagnostics, 2008
- Elevated Levels of FMR1 mRNA in Carrier Males: A New Mechanism of Involvement in the Fragile-X SyndromeThe American Journal of Human Genetics, 2000
- FMRP expression as a potential prognostic indicator in fragile X syndromeAmerican Journal of Medical Genetics, 1999